1. Home
  2. AURA vs PEO Comparison

AURA vs PEO Comparison

Compare AURA & PEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • PEO
  • Stock Information
  • Founded
  • AURA 2007
  • PEO 1929
  • Country
  • AURA United States
  • PEO United States
  • Employees
  • AURA N/A
  • PEO N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • PEO Finance/Investors Services
  • Sector
  • AURA Health Care
  • PEO Finance
  • Exchange
  • AURA Nasdaq
  • PEO Nasdaq
  • Market Cap
  • AURA 572.0M
  • PEO 617.0M
  • IPO Year
  • AURA 2021
  • PEO N/A
  • Fundamental
  • Price
  • AURA $9.47
  • PEO $24.16
  • Analyst Decision
  • AURA Strong Buy
  • PEO
  • Analyst Count
  • AURA 4
  • PEO 0
  • Target Price
  • AURA $23.00
  • PEO N/A
  • AVG Volume (30 Days)
  • AURA 184.2K
  • PEO 35.4K
  • Earning Date
  • AURA 11-12-2024
  • PEO 01-01-0001
  • Dividend Yield
  • AURA N/A
  • PEO 5.93%
  • EPS Growth
  • AURA N/A
  • PEO N/A
  • EPS
  • AURA N/A
  • PEO N/A
  • Revenue
  • AURA N/A
  • PEO N/A
  • Revenue This Year
  • AURA N/A
  • PEO N/A
  • Revenue Next Year
  • AURA N/A
  • PEO N/A
  • P/E Ratio
  • AURA N/A
  • PEO N/A
  • Revenue Growth
  • AURA N/A
  • PEO N/A
  • 52 Week Low
  • AURA $6.63
  • PEO $19.22
  • 52 Week High
  • AURA $12.38
  • PEO $23.80
  • Technical
  • Relative Strength Index (RSI)
  • AURA 39.43
  • PEO 56.84
  • Support Level
  • AURA $10.48
  • PEO $24.17
  • Resistance Level
  • AURA $11.29
  • PEO $24.50
  • Average True Range (ATR)
  • AURA 0.56
  • PEO 0.28
  • MACD
  • AURA -0.18
  • PEO 0.03
  • Stochastic Oscillator
  • AURA 2.67
  • PEO 71.90

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About PEO Adams Natural Resources Fund Inc.

Adams Natural Resources Fund Inc is a closed-end equity investment company specializing in energy and other natural resources stocks. The investment objectives of the fund are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. Its portfolio of investments comprises of different sector investments such as in the energy sector and basic materials.

Share on Social Networks: